Thomas Stratford

Direttore/Membro del Consiglio presso Kyowa Kirin International Plc

Health Technology

Consumer Services

Profilo

Thomas Stratford is currently a Director at Kyowa Kirin International Plc.
He previously worked as a Principal at GSK Plc.
Dr. Stratford holds a doctorate degree from King's College London.

Posizioni attive di Thomas Stratford

Società	Posizione	Inizio
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Thomas Stratford

Precedenti posizioni note di Thomas Stratford

Società	Posizione	Fine
GSK PLC	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Thomas Stratford

Formazione di Thomas Stratford

King's College London

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas Stratford

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
GSK PLC	Health Technology

Aziende private	1
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.	Health Technology